Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,970 | 23,120 | 12,490 | 12,809 | 14,612 |
| Marketable Securities | 77,725 | 67,121 | 60,302 | 57,930 | 72,946 |
| Receivables | 2,608 | 1,698 | 1,789 | 1,747 | 6,397 |
| TOTAL | $106,047 | $95,372 | $78,114 | $75,570 | $98,748 |
| Non-Current Assets | |||||
| PPE Net | 85,265 | 85,996 | 86,051 | 85,026 | 84,573 |
| Intangibles | 26,438 | 26,738 | 27,038 | 27,338 | 27,638 |
| Other Non-Current Assets | 964 | 861 | 946 | 974 | 1,021 |
| TOTAL | $112,667 | $113,595 | $114,035 | $113,338 | $113,232 |
| Total Assets | $218,714 | $208,967 | $192,149 | $188,908 | $211,980 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,751 | 4,736 | 4,721 | 4,705 | 4,691 |
| Accounts payable and accrued liabilities | 6,883 | 3,751 | 2,802 | 3,495 | 7,574 |
| Accrued Expenses | 6,787 | 8,032 | 7,295 | 5,682 | 6,945 |
| TOTAL | $57,463 | $48,319 | $38,636 | $32,948 | $38,710 |
| Non-Current Liabilities | |||||
| Long Term Debt | 32,189 | 32,384 | 32,568 | 32,748 | 32,940 |
| Deferred Revenues | 39,042 | 31,800 | 23,818 | 19,066 | 19,500 |
| Other Non-Current Liabilities | 720 | 715 | 699 | 677 | 644 |
| TOTAL | $75,449 | $80,794 | $59,611 | $47,561 | $51,676 |
| Total Liabilities | $132,912 | $129,113 | $98,247 | $80,509 | $90,386 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,226 | 9,222 | 9,108 | 9,084 | 9,080 |
| Common Shares | 64 | 64 | 64 | 63 | 63 |
| Retained earnings | -297,430 | -303,344 | -289,223 | -274,381 | -261,115 |
| Other shareholders' equity | -54 | -59 | -26 | -40 | -20 |
| TOTAL | $85,802 | $79,854 | $93,902 | $108,399 | $121,594 |
| Total Liabilities And Equity | $218,714 | $208,967 | $192,149 | $188,908 | $211,980 |